Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

Similar articles for PubMed (Select 9204220)

1.

Comparing compliance patterns between randomized treatments.

Vrijens B, Goetghebeur E.

Control Clin Trials. 1997 Jun;18(3):187-203.

PMID:
9204220
2.

Patterns of compliance with once versus twice daily antihypertensive drug therapy in primary care: a randomized clinical trial using electronic monitoring.

Leenen FH, Wilson TW, Bolli P, Larochelle P, Myers M, Handa SP, Boileau G, Tanner J.

Can J Cardiol. 1997 Oct;13(10):914-20. Review.

PMID:
9374947
3.

Efficacy of a home blood pressure monitoring programme on therapeutic compliance in hypertension: the EAPACUM-HTA study.

Márquez-Contreras E, Martell-Claros N, Gil-Guillén V, de la Figuera-Von Wichmann M, Casado-Martínez JJ, Martin-de Pablos JL, Figueras M, Galera J, Serra A; Compliance Group of the Spanish Society of Hypertension (SEE).

J Hypertens. 2006 Jan;24(1):169-75.

PMID:
16331115
4.

Practical properties of some structural mean analyses of the effect of compliance in randomized trials.

Fischer-Lapp K, Goetghebeur E.

Control Clin Trials. 1999 Dec;20(6):531-46.

PMID:
10588294
5.

Pilot study of a Web-based compliance monitoring device for patients with congestive heart failure.

Artinian NT, Harden JK, Kronenberg MW, Vander Wal JS, Daher E, Stephens Q, Bazzi RI.

Heart Lung. 2003 Jul-Aug;32(4):226-33.

PMID:
12891162
6.

The role of angiotensin II type 1 receptor antagonists in elderly patients with hypertension.

Thomas GN, Chan P, Tomlinson B.

Drugs Aging. 2006;23(2):131-55. Review.

PMID:
16536636
7.

Improved blood pressure control by monitoring compliance with antihypertensive therapy.

Waeber B, Vetter W, Darioli R, Keller U, Brunner HR.

Int J Clin Pract. 1999 Jan-Feb;53(1):37-8.

PMID:
10344064
8.

Estimating the causal effect of compliance on binary outcome in randomized controlled trials.

Goetghebeur E, Molenberghs G, Katz J.

Stat Med. 1998 Feb 15;17(3):341-55.

PMID:
9493258
10.

The medication Adherence and Blood Pressure Control (ABC) trial: a multi-site randomized controlled trial in a hypertensive, multi-cultural, economically disadvantaged population.

Gerin W, Tobin JN, Schwartz JE, Chaplin W, Rieckmann N, Davidson KW, Goyal TM, Jhalani J, Cassells A, Feliz K, Khalida C, Diaz-Gloster M, Ogedegbe G.

Contemp Clin Trials. 2007 Jul;28(4):459-71. Epub 2007 Jan 12.

PMID:
17287150
11.

A design for testing interventions to improve adherence within a hypertension clinical trial.

Johnson BF, Hamilton G, Fink J, Lucey G, Bennet N, Lew R.

Control Clin Trials. 2000 Feb;21(1):62-72.

PMID:
10660004
12.

All that glisters is not gold: a comparison of electronic monitoring versus filled prescriptions--an observational study.

Wetzels GE, Nelemans PJ, Schouten JS, van Wijk BL, Prins MH.

BMC Health Serv Res. 2006 Feb 10;6:8.

13.

Electronic pill-boxes in the evaluation of antihypertensive treatment compliance: comparison of once daily versus twice daily regimen.

Andrejak M, Genes N, Vaur L, Poncelet P, Clerson P, Carré A.

Am J Hypertens. 2000 Feb;13(2):184-90.

PMID:
10701819
14.

Compliance, electronic monitoring and antihypertensive drugs.

Mallion JM, Baguet JP, Siche JP, Tremel F, de Gaudemaris R.

J Hypertens Suppl. 1998 Jan;16(1):S75-9. Review.

PMID:
9534102
15.

Impact of supportive measures on drug adherence in patients with essential hypertension treated with valsartan: the randomized, open-label, parallel group study VALIDATE.

Düsing R, Handrock R, Klebs S, Tousset E, Vrijens B.

J Hypertens. 2009 Apr;27(4):894-901. doi: 10.1097/HJH.0b013e328323f9be.

PMID:
19300114
16.

The effect of prescribed daily dose frequency on patient medication compliance.

Eisen SA, Miller DK, Woodward RS, Spitznagel E, Przybeck TR.

Arch Intern Med. 1990 Sep;150(9):1881-4.

PMID:
2102668
17.
18.

Measurement of compliance with naltrexone in the treatment of alcohol dependence: research and clinical implications.

Namkoong K, Farren CK, O'Connor PG, O'Malley SS.

J Clin Psychiatry. 1999 Jul;60(7):449-53.

PMID:
10453799
19.

Patient compliance in rheumatoid arthritis, polymyalgia rheumatica, and gout.

de Klerk E, van der Heijde D, Landewé R, van der Tempel H, Urquhart J, van der Linden S.

J Rheumatol. 2003 Jan;30(1):44-54. Erratum in: J Rheumatol. 2003 Feb;30(2):423.

PMID:
12508389
20.

Blood pressure levels, risk factors and antihypertensive treatments: lessons from the SHEAF study.

Mallion JM, Genès N, Vaur L, Clerson P, Vaïsse B, Bobrie G, Chatellier G.

J Hum Hypertens. 2001 Dec;15(12):841-8.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk